Although peak may have higher sensitivity than post-treadmill exercise echocardiography (EE) for the detection of coronary artery disease (CAD), its prognostic value remains unknown. We sought to assess the relative values of peak and post-EE for predicting outcome in patients with known/suspected CAD.
Introduction
Exercise echocardiography (EE) is a recognized method for diagnosis and risk stratification of patients with known or suspected coronary artery disease (CAD). 1 -10 Its accuracy and prognostic value are similar to those of nuclear myocardial perfusion imaging. 9 -10 Nevertheless, as the cost is lower and safety is higher, an expansion of this method is likely expected. Exercise echocardiography should be the first choice for patients referred to stress echocardiography who are able to exercise, 11 -12 and within the EE modalities, treadmill EE is widely used. However, one of the pitfalls of this latter technique, when compared with pharmacological stress echocardiography or semi-supine bicycle, is that images are not acquired at peak exercise. This may lead to underestimation of the ischaemic burden, as heart rate and blood pressure can rapidly recover after cessation of exercise, 13 particularly in young patients and patients under the effect of beta-blockers or other drugs. In fact, current guidelines state that imaging at peak exercise is not feasible with treadmill. 11 -12 Nevertheless, our group has demonstrated that peak treadmill EE is feasible and has higher sensitivity and accuracy than post-exercise treadmill imaging. 14 -16 However, the prognostic value of this method has not been evaluated. In particular, it is unknown whether ischaemia limited to peak exercise has the same prognostic significance as ischaemia detected at both peak and post-exercise imaging. Also it is unknown whether the prognostic information offered by peak imaging enhances that of post-EE. Therefore, the aim of this study was to assess whether peak treadmill EE increases the value of the traditionally performed post-treadmill EE to predict mortality and major adverse cardiac events (MACE) in patients with confirmed or suspected CAD.
Methods Patients
A total of 3000 consecutive patients with a first treadmill EE performed at our institution between 1 August 2002 and 15 September 2006 were considered for inclusion. Patients were included if they had a complete EE study available, including peak and post-exercise images; in addition, post-exercise images had to be acquired within 40 s after the end of exercise. Of the 3000 patients, 53 (1.8%) were excluded: 14 because peak imaging was unfeasible due to premature cessation of exercise or technical problems and five because the complete post-exercise study was not acquired within the first 40 s of the end of the exercise. In addition, 34 patients referred for evaluation of valvular disease or cardiomyopathies were also excluded. Therefore, the final patient's group was made up of 2947 patients. All of them gave informed consent before testing. Main reasons for referring these patients to EE included chest pain in 2178 patients (73.9%), functional evaluation after myocardial infarction and/or revascularization procedures in 554 patients (18.8%), functional assessment of known coronary lesions in 58 patients (2%), previous non-diagnostic ECG exercise testing in 79 patients (2.7%), and other reasons in 78 patients (2.6%).
Whenever possible, beta-blocker therapy was discontinued for at least 48 h before testing. However, 6.6% of the patients were still under the influence of beta-blocker drugs at the time of their tests.
Exercise treadmill testing
Heart rate, blood pressure, and a 12-lead electrocardiogram were obtained at baseline and at each stage of the exercise protocol. Patients were encouraged to perform a treadmill exercise test (Bruce protocol 86.6%, modified Bruce 4.2%, modified Bruce for sportive people 8.6%, Naughton 0.6%), until they reached an endpoint. Exercise endpoints included physical exhaustion, significant arrhythmia, severe hypertension (systolic blood pressure .240 mmHg or diastolic blood pressure .110 mmHg), or severe hypotensive response (decrease .20 mmHg in systolic blood pressure from baseline). Ischaemic ECG abnormalities during the test were defined as the development of ST-segment deviation of !1 mm which was horizontal or sloping away from the isoelectric line 80 ms after the J point, in patients with normal baseline ST-segment. The resting ECG was considered non-diagnostic in the presence of left bundle branch block, pre-excitation, paced rhythm, repolarization abnormalities, or treatment with digoxin.
Exercise echocardiography and echocardiographic analysis
Two-dimensional echocardiography was performed in three apical views (long-axis, four-chambers, and two-chambers) and two parasternal views (long-axis and short-axis) at baseline, peak exercise, 14 -16 and in the immediate post-exercise period. Peak and postexercise images were obtained using a continuous imaging capture system, the former with the patient still exercising, the second lying in the table. Peak imaging was performed, when signs of exhaustion were present or an endpoint was achieved. If necessary, patients were asked to walk quickly rather than run, to decrease body and respiratory movements. The transducer was firmly positioned on the apical and parasternal area by applying slight pressure to the patient's back with the left hand, so maintaining the patient between the transducer and the left hand, to avoid movement. Imaging acquisition was performed online and stored on an optical disk. The images corresponding to each view having the best quality at peak and at postexercise were chosen for comparison with rest images. Echocardiographic two-dimensional analysis was performed on a digital quadscreen display system. Regional wall motion was evaluated with a 16-segment model of the left ventricle. 17 Each segment was graded on a four-point scale, with normal wall motion scoring ¼ 1, hypokinetic ¼ 2, akinetic ¼ 3, and dyskinetic ¼ 4. However, isolated hypokinesia of the infero-basal or septal basal segment were not considered abnormal, except when an adjacent segment was also abnormal. 18 Wall motion score index (WMSI) was calculated at rest, peak, and post-exercise as the sum of the scores divided by the number of segments. The changes in WMSI (DWMSI) from rest to peak exercise, from rest to post-exercise, and from peak to post-exercise (DWMSI Pk-Post) were also calculated. Left ventricular ejection fraction (LVEF) at rest, peak, and post-exercise was also visually estimated. 19 Reading of resting and peak images and reading of resting and post-exercise images were performed in separate days by two observers; in case of disagreement a third observer was required. Ischaemia was defined as the development of new or worsening wall motion abnormalities (WMA) with exercise (i.e. DWMSI . 0). The entire information about the clinical, ECG, haemodynamic, and echocardiographic response to exercise was provided to the clinicians in charge of the patients, with the exception of the specific time at which ischaemia was detected (peak, post-exercise, or both).
Patients with poor imaging quality were not excluded. The percentage of patients in whom 14 segments could be assessed was 3% at rest, 6.5% at peak exercise, and 6% at post-exercise.
Follow-up and endpoints
Follow-up was obtained by review of hospital databases, medical records, and death certificates, as well as by telephone interviews when necessary.
Endpoints were all-cause mortality and MACE, i.e. cardiac death and non-fatal myocardial infarction. Cardiac death was defined as death due to acute myocardial infarction, congestive heart failure, lifethreatening arrhythmias, or cardiac arrest; unexpected, otherwise unexplained sudden death was also considered cardiac death. Myocardial infarction was defined as the appearance of new symptoms of myocardial ischaemia or ischaemic ECG changes accompanied by increases in markers of myocardial necrosis. Revascularization procedures during follow-up were collected, although they were not considered events as EE results might have influenced patient management.
Statistical analysis
Categorical variables were reported as percentages and comparison between groups based on the x 2 test. Continuous variables were reported as mean + standard deviation and differences were assessed with the unpaired t-test or Mann-Whitney U test as appropriate.
Intra-and inter-observer variabilities for the assessment of WMA at rest, peak exercise ischaemia, and post-exercise ischaemia were evaluated by two-independent observers in a sample of 25 randomly selected studies. Percentage of agreement and kappa (k) values are given.
Cumulative event curves were estimated by the Kaplan-Meier method and compared by the log-rank test. For the MACE analysis, patients were censored at the time of a coronary revascularization procedure or non-cardiac death. For analysis of overall mortality, patients were not censored. 20 Univariable and multivariable associations of clinical, exercise, and EE variables with the endpoints were assessed with Cox's proportional hazard model. Variables were selected in a stepwise forward selection manner. Hazard ratios with 95% confidence intervals were estimated. Two models were built: in Model 1 peak ischaemia was assessed; in Model 2 we assessed post-exercise ischaemia.
The incremental value of EE results over clinical, resting echocardiographic, and exercise treadmill testing variables was assessed in five modelling steps in the same order as patients are usually evaluated in clinical practice. The first step was based on clinical data. Resting echocardiographic data was then added in the following step. The third step consisted of haemodynamic data obtained during exercise. In the fourth step, the post-exercise WMSI was added. To explore the significance of the addition of peak imaging to the post-exercise imaging information the change in WMSI between peak and post-exercise (DWMSI Pk-Post) was entered in the final step. In case of variables with similar meaning, continuous variables were chosen instead of dichotomous variables. In case of continuous variables highly correlated (for example WMSI and LVEF), those having higher area under the curve in the receiver operator curve analysis were used. The x 2 value of each model and the incremental value of adding the different variables were estimated. A statistically significant increase in the global x 2 of the model defined incremental prognostic value. 21 Statistical analysis was performed using SPSS software, version 15.0 (SPSS, Chicago, IL, USA).
Results

Baseline and exercise echocardiographic characteristics
Of the 2947 patients, 544 (18.5%) developed new or worsening WMAs during the test (ischaemia). Patients with ischaemia had worse WMSI at peak than at post-exercise echocardiography (1.59 + 0.36 vs. 1.42 + 0.38, P , 0.001). Among the 544 patients with ischaemia, 124 (4.2%) had ischaemia limited to peak exercise and 420 (14.3%) had ischaemia at post-exercise. In most of the patients with post-exercise ischaemia, ischaemia at peak exercise was also detected (414, 98.3%). The WMSI was also worse at peak than at post-exercise imaging in these patients with ischaemia in both conditions (1.62 + 0.37 vs. 1.50 + 0.36, P , 0.001). Clinical and demographic characteristics of the patients with normal EE results, peak exercise ischaemia alone, and post-exercise ischaemia are summarized in Table 1 , whereas EE data are shown in Table 2 .
As expected, patients with ischaemia were more likely to be male or to have a history of myocardial infarction or coronary revascularization. More patients in this group had submaximal tests, symptoms, or ECG changes during exercise, and worse resting and exercise LV function. When compared with patients with post-exercise ischaemia, patients with peak ischaemia alone had better clinical, exercise testing, and echocardiographic characteristics, including lower age and lower prevalence of typical angina. Achieved metabolic equivalents (METs) were higher and the frequency of a positive exercise testing lower than in patients with post-exercise ischaemia. Peak and post-exercise LV function were also better in them. Complications during the exercise testing were rarely reported (0.03%). Nine patients had nonsustained ventricular tachycardia (two with post-exercise ischaemia, one with peak ischaemia alone) and one patient developed complete atrio-ventricular block during exercise. Atrial fibrillation/flutter or supraventricular tachycardia occurred in nine patients.
Intra-and inter-observer variability
There was 100% intra-observer agreement (k ¼ 1.0 + 0) and 96% inter-observer agreement (k ¼ 0.90 + 0.09) for the diagnosis of resting WMA. The intra-and inter-observer agreement for peak ischaemia were 92% (k ¼ 0.83 + 0.16) and 96% (k ¼ 0.91 + 0.09), respectively. For post-exercise ischaemia, the intra-observer agreement was 100% (k ¼ 1.0 + 0) and the inter-observer agreement was 87% (k ¼ 0.50 + 0.25).
Outcomes
During a mean follow-up of 1.9 + 1.6 years, 164 patients died.
Five-year mortality rate was 3.5% in patients without ischaemia, 15.3% in patients with peak ischaemia alone, and 14.0% in those with post-exercise ischaemia. Overall, 378 patients (12.8%) underwent revascularization procedures during follow-up (298 percutaneous coronary interventions and 94 coronary artery bypass grafting). As expected, revascularizations during follow-up were more frequent in patients with ischaemia than in patients with normal results (49.3 vs. 4.7%, P , 0.001). Also, revascularizations were more frequent in patients with postexercise ischaemia than in patients with peak ischaemia alone (55.1 vs. 30.0%, P , 0.001). A total of 88 patients had a MACE before any revascularization procedure or non-cardiac death, including 40 non-fatal myocardial infarctions and 48 cardiac deaths. Five-year MACE rate was 1.8% in the non-ischaemic group, 10.5% in the group with peak ischaemia alone, and 7.6% in the group with postexercise ischaemia. Figures 1 and 2 show the Kaplan-Meier mortality and MACE curves for the three groups of patients.
Specific characteristics and outcome in patients with peak ischaemia alone
Of the 124 patients with peak ischaemia alone, 80 patients (64.5%) had extensive ischaemia and 16 (12.9%) developed new or worsening WMA in a multi-vessel distribution. There were 19 overall deaths, 13 MACE, and 37 revascularization procedures during follow-up. Of these 124 patients with peak ischaemia alone, 69 patients did not have a history of CAD (myocardial infarction or revascularization). Even so, 10 of these 69 patients died, 5 had a MACE, and 16 underwent revascularizations. Moreover, of these 124 patients with ischaemia demonstrated only at peak exercise, 33 had no history of CAD, a normal resting echocardiogram, absence of angina during exercise testing, and either non-diagnostic ECG or absence of ST changes during exercise. However, five of these 33 patients having no evidence of CAD prior to exercise imaging died, one had a MACE, and five underwent coronary revascularization.
Values of peak and post-EE in patients with known/suspected CAD
Predictors of outcome
Variables associated with mortality and MACE in the univariate analysis included age, male gender, history of myocardial infarction, atrial fibrillation, abnormal resting ECG, resting WMA, ratepressure product, METs, peak WMSI, post-exercise WMSI, peak ischaemia, and post-exercise ischaemia ( Table 3) .
In the multivariate analysis, post-exercise WMSI was a significant independent predictor of MACE, whereas peak exercise WMSI remained an independent predictor of both total mortality and MACE (Tables 4 and 5).
Incremental prognostic value of peak stress echocardiography
The global x 2 of the clinical model for predicting all-cause mortality was 107 (P , 0.001); the addition of resting echocardiographic and exercise testing data added significantly to the model (x 2 166, P , 0.001); the subsequent addition of the post-EE results to the clinical, resting echocardiographic, and treadmill exercise data also provided incremental information for predicting total mortality (x 2 190, P ¼ 0.016). Finally, the addition of the increase in WMSI between peak and post-exercise imaging increased the x 2 to 196
The global x 2 of the clinical model for predicting MACE was 122 (P , 0.001); after adding resting echocardiography and treadmill exercise data, the global x 2 increased to 158 (P , 0.001); the subsequent addition of the post-EE results increased the global x 2 to 182 (P ¼ 0.028). Finally, after entering DWMSI Pk-Post, the global x 2 of the model increased to 192 (P ¼ 0.041).
Discussion
The main findings of this study were the following: first, patients with ischaemia limited to peak exercise have more favourable clinical and exercise testing characteristics, as well as resting and exercise LV function, than patients with post-exercise ischaemia. Likely due to this better picture, revascularization procedures were less frequently performed on them. Second, although according to their baseline and exercise testing characteristics a better outcome should be expected, the mid-term outcome was actually similar to that of patients with post-exercise ischaemia. Progression of CAD seems to be the more likely explanation for this finding. Third, the implementation of the EE information by peak exercise scanning achieved the detection of more patients at risk that by means of the currently recommended post-exercise imaging approach. 11 -12 One of five patients with inducible ischaemia would be deemed as a low risk patient, if we had only used post-exercise imaging. Moreover, even in patients with postexercise ischaemia, LV function was notoriously worse at peak than at post-exercise imaging, indicating that the ischaemic burden is currently underestimated by the classical approach. Therefore, the peak imaging approach makes ischaemia more recognizable in them. Indeed, although both peak WMSI in Model 1 and post-exercise WMSI in Model 2 independently predicted MACE, only the former had independent value for predicting overall mortality. Thus, treadmill EE by means of peak and post-exercise imaging acquisition appears to be a better method for risk stratification. In certain sense, this approach is similar to pharmacological stress echocardiography and semi-supine bicycle, where scanning may be performed at several stages through the test and the information provided is used for prognostic stratification. Even the subgroup of patients without known CAD having normal resting echocardiography and normal ECG exercise testing were at higher risk, if ischaemia at peak exercise was demonstrated. This information is particularly useful and timely in an era when new techniques in the field of CAD evaluation are emerging, such as computed tomography and magnetic resonance imaging, with tremendous implications in terms of cost, and, in the former case, other side effects like radiation exposure. .......... ............ ............ ............ ........... ............ ............ ............ ........... ............ ............ ............ ........... ............ ....... METs, metabolic equivalents. Heart rate at post-exercise imaging denotes the mean heart rate of the acquired images; positive exercise testing is defined as positive ECG and/or angina during the test. *P , 0.05 vs. peak ischaemia. † P , 0.01 vs. peak ischaemia. ‡ P , 0.05 vs. post-exercise ischaemia. § P , 0.01 vs. post-exercise ischaemia.
Values of peak and post-EE in patients with known/suspected CAD outcome, either by echocardiography 1 -9 or nuclear perfusion imaging, 10,22 the present study is the first one to assess the prognostic implications of peak and post-exercise treadmill EE in patients with suspected or demonstrated CAD. This study demonstrates that peak treadmill EE provides significant prognostic information for the prediction of mortality and cardiac events in patients who otherwise would have been considered as at low risk according to post-exercise echocardiography. The annualized mortality and MACE rate of 0.72 and 0.36% for patients with negative peak and post-EE is similar to previously reported figures for a negative exercise echocardiogram. 9 However, in patients with peak ischaemia alone, the annualized mortality rate of 2.86% and MACE rate of 1.84% places these patients in an intermediate risk group, similar to that of patients with the intermediate Duke score and positive but non-severe EE 3,7 and in fact not different from patients with post-exercise ischaemia. Although peak exercise imaging may also be obtained during supine bicycle, 23 -24 this method achieves lower oxygen consumption, and not all patients capable of exercising are able to exercise in a bicycle. 25 -27 We have previously reported the feasibility and higher sensitivity and accuracy of peak treadmill EE, when compared with postexercise imaging.
14 -16 The higher sensitivity of peak imaging is likely the reason why this technique increased the EE value for detecting patients with worse outcome. Although current guidelines state that post-exercise imaging should be accomplished within 60 -90 s of termination of exercise, 28 we have not included patients whose images were obtained 40 s beyond the end of exercise. This is pertinent because WMA may recover in less than 10 s after an ischaemic burden, as it has been seen in several studies during angioplasty. 29 -30 Other advantages of peak over post-exercise treadmill imaging are the possibility of scanning at any step of the protocol to evaluate patients in case of doubts about clinical symptoms or ECG changes, and the relative lack of hurry in contrast to the narrow time window for post-exercise imaging acquisition. In addition, peak imaging might increase the safety of the test as decisions about the convenience of stopping it can be promptly made. In this study, we extend the advantages of peak imaging by demonstrating its significant value for predicting events. Other non-significant analysed variables were: history of smoking, hypertension, hypercholesterolaemia, treatment with beta-blockers at the time of the exercise testing, resting heart rate, and resting rate -pressure product. ACE-I, angiotensin-converting enzyme inhibitors; ARAs, angiotensin receptor antagonists; WMA, wall motion abnormalities; WMSI, wall motion score index; LVEF, left ventricular ejection fraction; RPP, rate-pressure product; METs, metabolic equivalents; MAPHR, maximal age-predicted heart rate. Values of peak and post-EE in patients with known/suspected CAD On the basis of these results, we recommend peak imaging in each patient referred for EE. In case of clear positive findings at peak exercise, no further investigation would be necessary. In case of negative findings at peak exercise, post-exercise images should be acquired, due to the (rare) possibility of ischaemia developing only at post-exercise.
Limitations
As in most studies evaluating outcome after stratification techniques, the main limitation is that patients with ischaemic results were more likely to undergo revascularization procedures, and thus, the actual prognostic value of peak EE may have been significantly underestimated. This issue is illustrated by the fact that patients with post-exercise ischaemia who otherwise had more frequently positive clinical and ECG findings and lower exercise tolerance underwent revascularization more often than those with ischaemia limited to peak exercise.
Although the ischaemia relief time after exercise might further stratify patients with post-exercise ischaemia, this issue was not investigated in this study. Also, although scanning during EE is feasible and this information is useful, we only acquired peak and postexercise images.
Even though EE variables increased the predictive value of the models for predicting outcome, it should be pointed out the important impact of treadmill exercise testing variables. 31 -32 When compared with pharmacological stress echocardiography, the incremental value of treadmill EE is relatively lower because these powerful variables can also be studied.
Finally, we recognize that a comparison between peak treadmill EE and the more standardized peak semi-supine bicycle EE 33 in a large number of patients would be a useful first step before proposing peak treadmill EE. Thus, a study addressing this issue is warranted.
Conclusions
Peak treadmill EE provides significant prognostic information for predicting outcome in patients with known or suspected CAD, beyond the information based on post-exercise echocardiography.
Patients with myocardial ischaemia, who might be missed on the basis of the traditionally performed post-exercise treadmill echocardiography alone, may significantly benefit from appropriate management. 
